Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CER Credibility Lies In Methodology For Studies, Physician Tells BIO

Executive Summary

The credibility of comparative effectiveness research ultimately will be judged based on the methodology used to conduct the research, David Charles, associate professor and vice-chairman of neurology at Vanderbilt University Medical Center and chairman of the physician group Alliance for Patient Access, told attendees during a session at the Biotechnology Industry Organization International Convention.

You may also be interested in...



PCORI Shifts Focus To Dissemination Of Research Findings

The Patient-Centered Outcomes Research Institute expects its blueprint for disseminating the clinical comparative research it funds ready about when the first projects are complete in early 2014.

Dissemination Of CER Evidence Remains Key Challenge, PCORI Survey Suggests

Getting clinicians to access, let alone adopt, clinical comparative effectiveness research findings continues to loom as a key challenge, results from a recent PCORI survey suggest.

Thirteen Principles For Conducting CER, According To United BioSource Exec

During a recent DIA-sponsored conference, United BioSource Corp.’s Bryan Luce previewed a paper that will outline 13 principles that should be taken into account when developing comparative effectiveness research.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS053565

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel